KC,
I read the news which came out yesterday and I beleive it's responcible for the rise...
NOTHING related to video streaming alleged patent
;-))
CombiMatrix to Present at the UBS Warburg Global Life Sciences Conference
Wednesday, September 3, 2003 7:30 AM
- BusinessWire
NEWPORT BEACH, Calif., Sep 3, 2003 (BUSINESS WIRE) -- Acacia Research Corporation (CBMX)(ACTG) announced today that Dr. Amit Kumar, President and Chief Executive Officer of CombiMatrix, will provide a company overview at the UBS Warburg Global Life Sciences Conference. A live transmission of the presentation will take place at 10:00 AM (PST) / 1:00 PM (EST) on Wednesday, September 24, 2003.
To access the live audio webcast, please go to UBS Warburg's site at
www.ibb.ubs.com and click on the conference link. A replay of the presentation will be made available at the UBS Warburg site 3 hours after the actual presentation time and will be available until October 25, 2003.
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research Corporation comprises two operating groups, Acacia Technologies Group and CombiMatrix Group.
The CombiMatrix group is developing a platform technology to rapidly produce customizable active biochips, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. CombiMatrix's technology has a wide range of applications including DNA synthesis/diagnostics, drug discovery, and immunochemical detection. CombiMatrix's Express Track(SM) and siRNA Solutions™ are approaches to target diseases with siRNA compounds. The initial focus of Express Track(SM) are the following viral diseases:
Virus Collaborator
SARS NIAID/USAMRIID
HIV type 1 irsiCaixa-Dr. Bonaventura Clotet
HIV type 2 To Be Announced
West Nile virus To Be Announced
Human Papillomavirus type 16 To Be Announced
Human Herpes 8 (Kaposi's sarcoma) To Be Announced
Smallpox (Variola) To Be Announced
Influenza virus A To Be Announced
Influenza virus B To Be Announced
Hepatitis C To Be Announced